Benzohydrazid

Benzoylhydrazine

HCID 11955CAS 613-94-5

Grundinformationen

Standard-SMILES
NNC(=O)c1ccccc1
InChIKey
WARCRYXKINZHGQ-UHFFFAOYSA-N
Summenformel
C7H8N2O
Durchschnittliche Molmasse
136,15 g/mol
Monoisotopische Masse
136,06366288

Namen und Bezeichner

Bevorzugter Name
Benzoylhydrazine
IUPAC
benzohydrazide
Lokaler Name
Benzohydrazid
Englischer Name
Benzoyl hydrazine
Summenformel
C7H8N2O
Molmasse
136.15

Namen und Synonyme

Benzohydrazide613-94-5BenzoylhydrazineBENZHYDRAZIDEBenzoic hydrazideBenzoic acid hydrazideBenzoic acid, hydrazideBenzoyl hydrazideBenzohydrazineHydrazid kyseliny benzooveLLW11ZWZ20CHEBI:38454
Weitere Namen anzeigen
BENZOIC HYDRAZINEINHd 14
NSC-644RefChem:565091210-363-9Benzoyl hydrazinebenzoylhydrazideHydrazine, benzoyl-NSC 644DTXSID6020149

Datenbank-Bezeichner

CAS
613-94-5
PubChem CID
11955
DTXSID
DTXSID6020149
ChEMBL
CHEMBL125369
ChEBI
CHEBI:38454
UNII
LLW11ZWZ20
EC Number
210-363-9
Nikkaji
J30.698C

Eigenschaften

Berechnete Struktureigenschaften

XLogP
0,2
Polarare Oberfläche (TPSA)
55,1 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
1
Schwere Atome
10

Experimentelle und physikochemische Eigenschaften

LogPlog Kow = 0.19
Color/FormPlates from water
SolubilitySol in water and alc; slightly sol in ether, acetone, chloroform
Boiling Point267 °C (decomposes)
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/.
Melting Point115 °C

Physikochemische Eigenschaften

Schmelzpunkt
112 · 112-114 °C (lit.)
Siedepunkt
250.42 °C · 250.42°C (rough estimate)
Dichte
1.1778 · 1.1778 (rough estimate)
Brechungsindex
1.546 · 1.5460 (estimate)
storage temp.
Keep in dark place,Inert atmosphere,Room temperature
Löslichkeit
DMSO (Slightly), Methanol (Slightly)

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 5 Einträge

Danger

H301 (82.7%): Toxic if swallowed [Danger Acute toxicity, oral];H315 (92.3%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (90.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (86.5%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H351 (15.4%): Suspected of causing cancer [Warning Carcinogenicity]

P203, P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 52 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Gefahrenhinweise

Regulatory InformationBenzoic acid, hydrazide: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryIn animal experiments, causes somnolence and seizures after acute exposure and tumors after chronic exposure; [RTECS] May cause liver injury; [HSDB] An irritant; [MSDSonline] See Hydrazine.
Hazard Classes and CategoriesAcute Tox. 3 (82.7%);Skin Irrit. 2 (92.3%);Eye Irrit. 2 (90.4%);STOT SE 3 (86.5%);Carc. 2 (15.4%)
Hazardous Reactivities and IncompatibilitiesViolent reaction with benzeneseleninic acid.

Sicherheit und Schutzausrüstung

Disposal Methods · 1 Eintrag

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Personal Protective Equipment (PPE) · 1 Eintrag

... Vinyl coated hand protection, natural or reclaimed rubber protection, rubber aprons, and plastic eye and face protection ... used when working with small quantities. Where possibility of gross splashing exists, full protective clothing made of rubber, neoprene or vinyl-coated materials should be worn. For respiratory protection in situations where recommended tolerance limits ... exceeded, respiratory protective equipment... must be used. /Hydrazine and derivatives/

Toxikologische Informationen

Interactions · 1 Eintrag

Binary mixtures of the osteolathyrogens benzoic hydrazide and beta-aminopropionitrile were tested to determine the joint action for these chemicals, by evaluating induction of malformation and osteolathyrism in developing frog embryos. Exposures, starting with late-blastula stage embryos, were for 96-hr with solution renewal every 24-hr. Five treatments were examined, each chemical alone (i.e., 1:0 and 0:1 solutions) and three mixtures (i.e., 3:1, 1:1, and 1:3). Following exposure, embryos were evaluated grossly and the incidences of all types of malformations and osteolathyrogenic lesions were determined. Toxic unit analysis and isobole diagrams indicated these chemicals were concentration additive in inducing malformations and osteolathyrism. Therefore, benzoic hydrazide and beta-aminopropionitrile induce osteolathyrism, in Xenopus embryos, in a similar manner.

Adverse EffectsNeurotoxin - Other CNS neurotoxin;Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Ecotoxicity Excerpts · 1 Eintrag

/AQUATIC SPECIES/ Binary mixtures of the osteolathyrogens benzoic hydrazide and beta-aminopropionitrile were tested to determine the joint action for these chemicals, by evaluating induction of malformation and osteolathyrism in developing frog embryos. Exposures, starting with late-blastula stage embryos, were for 96-hr with solution renewal every 24-hr. Five treatments were examined, each chemical alone (i.e., 1:0 and 0:1 solutions) and three mixtures (i.e., 3:1, 1:1, and 1:3). Following exposure, embryos were evaluated grossly and the incidences of all types of malformations and osteolathyrogenic lesions were determined. Toxic unit analysis and isobole diagrams indicated these chemicals were concentration additive in inducing malformations and osteolathyrism. Therefore, benzoic hydrazide and beta-aminopropionitrile induce osteolathyrism, in Xenopus embryos, in a similar manner.

Non-Human Toxicity Excerpts · 3 Einträge

/HUMAN EXPOSURE STUDIES/ Large number of ... hydrazine derivatives are convulsants including ... benzhydrazide...

/HUMAN EXPOSURE STUDIES/ .../Benzhydrazide is among/ hydrazine deriv /which/ have been observed to cause alterations in liver function, fatty infiltration, or cellular damage. ... Characteristic liver pathology seen after effective doses of hepatotoxic hydrazines is fatty degeneration ... most marked in center of liver lobules.

/HUMAN EXPOSURE STUDIES/ There may also be damage to other organs, particularly kidney /after effective doses of hepatotoxic hydrazines incl benzhydrazide./ ... Other pathological changes, such as extramedullary hepatopoiesis, pigment (hemosiderin) deposition in cells, and vascular thrombosis, are secondary to blood cell destruction.

Populations at Special Risk · 1 Eintrag

Biological half-lives were significantly different among the three acetylation phenotypes (analysis of variance, P < 0.05): 3.94+/-1.70 hours for slow acetylators, 2.25+/-0.37 hours for intermediate acetylators, and 1.86+/-0.67 hours for rapid acetylators. /Hydrazine/

Antidote and Emergency Treatment · 5 Einträge

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... . Cover skin burns with dry, sterile dressings after decontamination ... . /Hydrazine and Related Compounds/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in respiratory arrest. Positive pressure ventilation techniques with a bag valve mask device may be beneficial. Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start an IV with D5W /SRP: "To keep open", minimal flow rate/. Use lactated Ringer's if signs of hypovolemia are present. Consider drug therapy for pulmonary edema ... . For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors for hypotension with a normal fluid volume. Watch for signs of fluid overload ... . Treat seizures with diazepam ... . Monitor for signs of hypoglycemia (decreased level of consciousness, tachycardia, pallor, dilated pupils, diaphoresis, and/or a dextrose strip or glucometer reading less than 50 mg/dl) and administer 50% dextrose if necessary. Draw blood sample before administration ... . Administer 1% solution methylene blue if patient is symptomatic with severe hypoxia, cyanosis, and cardiac compromise not responding to oxygen. ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Hydrazine and Related Compounds/

Specific treatment for exposure consists of thorough washing of all exposed skin areas with soap and water, copious irrigation of the eyes, and prompt removal of the patient from the source of exposure. /Hydrazines/

After inhalation, observation for progressive respiratory distress is necessary. Chest X-ray and arterial blood gases should be monitored. Administration of oxygen, intubation, and assisted ventilation may become necessary. Pneumonia and bronchitis need to be excluded. /Hydrazines/

For more Antidote and Emergency Treatment (Complete) data for BENZHYDRAZIDE (6 total), please visit the HSDB record page.

Regulatorische Informationen

Regulatory InformationBenzoic acid, hydrazide: Does not have an individual approval but may be used under an appropriate group standard

Sicherheitsdaten

wgk
3
tsca
TSCA listed
ridadr
UN 2811 6.1/PG 3
hs_code
29280090
RTECS-Nr.
DH1575000
risk_code
25-36/37/38

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 2 Einträge

Benzohydrazide yields benzoic acid in rabbit: El Masri, AM, Smith, JN, & Williams, RT, Biochem J, 68, 587 (1958). /from table/

... Benzohydrazide ... /is/ metabolized by rabbits to yield hippuric acid & hydrazine.

Verwendung und Herstellung

Uses · 2 Einträge

Used as a chemical intermediate for hydrazine-based products; [HSDB]

Chemical intermediate ... hydrazine-based products

General Manufacturing InformationBenzoic acid, hydrazide: ACTIVE

Anwendungen

BeschreibungDas Benzoesäurehydrazid bildet farblose, mäßig wasserlösliche Kristalle. Die Substanz besitzt nur wissenschaftliches Interesse.

VerwendenBenzoyl Hydrazine is an acyl hydrazide as potent antioxidant.

Anbieter50 Anbieter

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]
爱斯特(成都)生物制药股份有限公司+86-28-85122536 85324413 · [email protected]

Zugehörige Reaktionen

288

Verknüpfte Notizen

Wird geladen…